MACEs | |||
---|---|---|---|
Exposure | Non-adjusted a | Minor-adjusted b | Fully adjusted c |
FG/HDL-C ratio | 1.09 (1.05, 1.13), P < 0.01 | 1.10 (1.06, 1.15), P < 0.01 | 1.09 (1.04, 1.14), P < 0.01 |
FG/HDL-C ratio grouping | |||
Q1 | Ref | Ref | Ref |
Q2 | 0.93 (0.70, 1.22), P = 0.58 | 0.95 (0.72, 1.26), P = 0.75 | 0.98 (0.73, 1.30), P = 0.88 |
Q3 | 0.89 (0.68, 1.18), P = 0.43 | 1.00 (0.76, 1.33), P = 0.98 | 1.03 (0.76, 1.38), P = 0.86 |
Q4 | 1.42 (1.10, 1.82), P < 0.01 | 1.57 (1.21, 2.03), P < 0.01 | 1.49 (1.11, 1.99), P < 0.01 |
CV death | |||
Exposure | Non-adjusted a | Minor-adjusted b | Fully adjusted d |
FG/HDL-C ratio | 1.11 (1.07, 1.16), P < 0.01 | 1.13 (1.08, 1.18), P < 0.01 | 1.11 (1.04, 1.19), P < 0.01 |
FG/HDL-C ratio grouping | |||
Q1 | Ref | Ref | Ref |
Q2 | 0.95 (0.68, 1.31), P = 0.74 | 0.98 (0.70, 1.38), P = 0.92 | 1.01 (0.59, 1.71), P = 0.98 |
Q3 | 0.82 (0.58, 1.15), P = 0.26 | 0.94 (0.66, 1.33), P = 0.71 | 0.83 (0.48, 1.46), P = 0.53 |
Q4 | 1.56 (1.16, 2.10), P < 0.01 | 1.77 (1.30, 2.39), P < 0.01 | 1.69 (1.01, 1.41), P = 0.04 |